Innovative AI-Driven Solutions To Address The Growing Complexity Of APIs

Modern drug development is challenged by increasingly complex APIs, which lengthen synthetic pathways and hinder efficient manufacturing. These complexities also create intricate supply chains, delaying preclinical timelines.
To address these challenges, Lonza has harnessed the power of AI-driven computer-aided synthesis planning (CASP). Our advanced technology identifies the most efficient and reliable synthetic routes to a target molecule, optimizing the drug development process. By combining our deep manufacturing expertise with award-winning AI, we've tailored CASP to accelerate preclinical route design.
Our AI-Enabled Route Scouting Service delivers:
- Shorter synthetic pathways: Streamlining production and reducing costs.
- Optimized supply chains: Mitigating risks and ensuring reliable sourcing.
- Faster route selection: Accelerating time to IND filing.
Lonza's subject matter experts, equipped with this cutting-edge technology, are empowering our partners to overcome API complexity and achieve rapid IND readiness.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.